Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
13.58
+0.02 (0.15%)
At close: Jul 8, 2026, 4:00 PM EDT
13.70
+0.12 (0.88%)
After-hours: Jul 8, 2026, 6:08 PM EDT
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $827.32 million as of July 8, 2026. Its market cap has decreased by -22.80% in one year.
Market Cap
827.32M
Enterprise Value
553.31M
1-Year Change
-22.80%
Ranking
Category
Stock Price
$13.58
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $827.32M, an increase of 420.11%. That is a compound annual growth rate of 37.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 827.32M | -28.33% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 894.58M |
| Phathom Pharmaceuticals | 889.62M |
| Theravance Biopharma | 872.79M |
| Geron | 872.47M |
| Alto Neuroscience | 869.63M |
| Aura Biosciences | 853.72M |
| ARS Pharmaceuticals | 850.04M |
| CytomX Therapeutics | 831.63M |